Inhibitors | Comment | Organism | Structure |
---|---|---|---|
allopurinol | i.e. 1, 5-dihydro-4H-pyrazolo [3, 4-d]pyrimidine-4-one, allopurinol is a substrate and a competitive inhibitor for xanthine oxidase, it binds irreversibly at the active site reducing molybdenum VI to IV, and it is used for treatment of hyperuricemia | Homo sapiens | |
allopurinol | i.e. 1, 5-dihydro-4H-pyrazolo [3, 4-d]pyrimidine-4-one, allopurinol is a substrate and a competitive inhibitor for xanthine oxidase, it binds irreversibly at the active site reducing molybdenum VI to IV, and it is used for treatment of hyperuricemia | Rattus norvegicus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | Homo sapiens | enzyme inhibitors exert beneficial effect on endothelial dysfunction, mechanisms, overview, mechanism of action in cardiovascular disease, overview | ? | - |
? | |
additional information | Rattus norvegicus | enzyme inhibitors exert beneficial effect on endothelial dysfunction, mechanisms, overview, mechanism of action in cardiovascular disease, overview | ? | - |
? | |
xanthine + H2O + O2 | Homo sapiens | urate is involved in development of endothelial dysfunction, overview | urate + H2O2 | - |
? | |
xanthine + H2O + O2 | Rattus norvegicus | urate is involved in development of endothelial dysfunction, overview | urate + H2O2 | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Rattus norvegicus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
endothelium | - |
Homo sapiens | - |
endothelium | - |
Rattus norvegicus | - |
heart | - |
Homo sapiens | - |
heart | - |
Rattus norvegicus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
allopurinol + H2O + O2 | allopurinol is a substrate and a competitive inhibitor for xanthine oxidase, it binds irreversibly at the active site reducing molybdenum VI to IV | Homo sapiens | oxypurinol + H2O2 | - |
? | |
allopurinol + H2O + O2 | allopurinol is a substrate and a competitive inhibitor for xanthine oxidase, it binds irreversibly at the active site reducing molybdenum VI to IV | Rattus norvegicus | oxypurinol + H2O2 | - |
? | |
additional information | enzyme inhibitors exert beneficial effect on endothelial dysfunction, mechanisms, overview, mechanism of action in cardiovascular disease, overview | Homo sapiens | ? | - |
? | |
additional information | enzyme inhibitors exert beneficial effect on endothelial dysfunction, mechanisms, overview, mechanism of action in cardiovascular disease, overview | Rattus norvegicus | ? | - |
? | |
xanthine + H2O + O2 | urate is involved in development of endothelial dysfunction, overview | Homo sapiens | urate + H2O2 | - |
? | |
xanthine + H2O + O2 | urate is involved in development of endothelial dysfunction, overview | Rattus norvegicus | urate + H2O2 | - |
? | |
xanthine + H2O + O2 | production of superoxide radicals, mechanism of stepwise enzyme reduction during catalysis, overview | Homo sapiens | urate + H2O2 | - |
? | |
xanthine + H2O + O2 | production of superoxide radicals, mechanism of stepwise enzyme reduction during catalysis, overview | Rattus norvegicus | urate + H2O2 | - |
? |